Recently, our lab reported findings that demonstrate a switch in EGFR function between primary and metastatic tumors.31 In this study, EGF treatment of EGFR-amplified primary tumor cells resulted in increased proliferation, and these cells were particularly sensitive to EGFR inhibition. The gene discussed is EGFR; the disease is neoplasm.